187 related articles for article (PubMed ID: 16388798)
1. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
Gillard M; Chatelain P
Eur J Pharmacol; 2006 Jan; 530(3):205-14. PubMed ID: 16388798
[TBL] [Abstract][Full Text] [Related]
2. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
[TBL] [Abstract][Full Text] [Related]
3. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H
Kobayashi C; Tanaka A; Yasuda T; Hishinuma S
Biochem Pharmacol; 2020 Oct; 180():114185. PubMed ID: 32738199
[TBL] [Abstract][Full Text] [Related]
4. Differential Regulation of Thermodynamic Binding Forces of Levocetirizine and (
Hishinuma S; Tamura Y; Kobayashi C; Akatsu C; Shoji M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558340
[TBL] [Abstract][Full Text] [Related]
5. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
Wallace RM; Young JM
Mol Pharmacol; 1983 Jan; 23(1):60-6. PubMed ID: 6135145
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
Hishinuma S; Young JM
Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
[TBL] [Abstract][Full Text] [Related]
7. Modulation of antagonist binding to histamine H1-receptors by sodium ions and by 2-amino-2-hydroxymethyl-propan-1,3-diol HCl.
Gibson WJ; Roques TW; Young JM
Br J Pharmacol; 1994 Apr; 111(4):1262-8. PubMed ID: 7913374
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).
Gillard M; Van Der Perren C; Moguilevsky N; Massingham R; Chatelain P
Mol Pharmacol; 2002 Feb; 61(2):391-9. PubMed ID: 11809864
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells.
Moguilevsky N; Varsalona F; Guillaume JP; Noyer M; Gillard M; Daliers J; Henichart JP; Bollen A
J Recept Signal Transduct Res; 1995; 15(1-4):91-102. PubMed ID: 8903934
[TBL] [Abstract][Full Text] [Related]
11. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
Yeramian E; Garbarg M; Schwartz JC
Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
[TBL] [Abstract][Full Text] [Related]
12. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
13. Temperature-dependence of the kinetics of the binding of [3H]-(+)-N-methyl-4-methyldiphenhydramine to the histamine H1-receptor: comparison with the kinetics of [3H]-mepyramine.
Treherne JM; Young JM
Br J Pharmacol; 1988 Jul; 94(3):811-22. PubMed ID: 3179614
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
Laduron PM; Janssen PF; Gommeren W; Leysen JE
Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
[TBL] [Abstract][Full Text] [Related]
15. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
Rose C; Quach TT; Llorens C; Schwartz JC
Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
[TBL] [Abstract][Full Text] [Related]
16. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
17. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization.
Hishinuma S; Sato Y; Kobayashi Y; Komazaki H; Saito M
J Pharmacol Sci; 2008 May; 107(1):66-79. PubMed ID: 18446005
[TBL] [Abstract][Full Text] [Related]
18. Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells.
Gillard M; Van der Perren C; Massingham R; Chatelain P
Inflamm Res; 2002 Apr; 51 Suppl 1():S77-8. PubMed ID: 12013420
[No Abstract] [Full Text] [Related]
19. The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.
Matsumoto Y; Funahashi J; Mori K; Hayashi K; Yano H
Pharmacology; 2008; 81(3):266-74. PubMed ID: 18268402
[TBL] [Abstract][Full Text] [Related]
20. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
